Patents Assigned to VAXXIT SRL
  • Method of improving immune function in HIV-infected subjects on HAART by administering HIV-1 TAT
    Patent number: 9630995
    Abstract: Native Tat, when administered to patients with HIV infection, or who are otherwise immunocompromised, is capable of restoring immune functions so as to recognize recall antigens, and to inhibit replication and key signs of HIV disease and other persistent infections and/or their progression.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: April 25, 2017
    Assignee: VAXXIT SRL
    Inventor: Barbara Ensoli
  • IMMUNE THERAPY
    Publication number: 20130058973
    Abstract: Native Tat, when administered to patients with HIV infection, or who are otherwise immunocompromised, is capable of restoring immune functions so as to recognise recall antigens, and to inhibit replication and key signs of HIV disease and other persistent infections and/or their progression.
    Type: Application
    Filed: March 21, 2011
    Publication date: March 7, 2013
    Applicant: VAXXIT SRL
    Inventor: Barbara Ensoli